Skip to main content
رجوع
Watch Compare

Cocrystal Pharma, Inc.

جودة البيانات: 83%
COCP
NASDAQ Manufacturing Chemicals
KWD 1.53
▲ KWD 0.10 (6.99%)
6 months return
—
Momentum
Neutral
ROE
-135.84%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-135.84%
أقل من متوسط القطاع (-54.49%)
ROIC-91.35%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio5.78
Interest Coverage-67.31

التقييم

PE (TTM|NTM)
-2.28 | -1.95
أقل من متوسط القطاع (-1.50)
P/B Ratio2.62
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -8.20 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

3 محللين
Buy
+422.9%
upside to target
الحالي
KWD 1.53
Consensus Target
KWD 8.00
KWD 6.00
أدنى
KWD 10.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-1.95
ربحية السهم المستقبلية
-KWD 0.64
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -KWD 0.15 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -KWD 0.23 -KWD 0.20 -KWD 0.19 -KWD 0.17 — —
Estimate -KWD 0.51 -KWD 0.30 -KWD 0.22 -KWD 0.18 -KWD 0.15 -KWD 0.17
المفاجأة +54.46% +33.33% +11.63% +2.86% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -135.84% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -8.83 M
ROE -135.84% ROA -93.20%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8.20 M
ROIC -91.35% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 5.78
Debt / Equity N/A Current Ratio 5.78
Interest Coverage -67.31 Asset Turnover N/A
Working Capital 7.26 M Tangible Book Value 7.67 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -2.28 · EV/EBITDA: N/A
P/E Ratio -2.28 Forward P/E -1.95
P/B Ratio 2.62 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -40.76%
Market Cap 20.13 M Enterprise Value 20.13 M

Per Share

EPS: -0.78 · FCF/Share: -0.60
EPS (Diluted TTM) -0.78 Revenue / Share N/A
FCF / Share -0.60 OCF / Share -0.59
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 92.90% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 92.90%
SBC-Adj. FCF -8.67 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 2.01 M
Net Income -8.83 M -17.50 M -17.98 M -38.84 M -14.19 M
EPS (Diluted) -0.78 -1.72 -1.87 — —
Gross Profit — — — — —
Operating Income -9.02 M -17.88 M -18.56 M -38.83 M -14.22 M
EBITDA — — — — —
R&D Expenses 5.06 M 12.54 M 15.17 M 12.39 M 8.79 M
SG&A Expenses — — — — —
D&A 72,000.0 126,000.0 189,000.0 185,000.0 190,000.0
Interest Expense -134,000.0 -537,000.0 -640,000.0 2,000.0 4,000.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 9.71 M 13.46 M 31.26 M 40.84 M 79.39 M
Total Liabilities 3.38 M 3.93 M 4.88 M 1.27 M 1.84 M
Shareholders' Equity 6.33 M 9.52 M 26.38 M 39.57 M 77.55 M
Total Debt — — — — —
Cash & Equivalents 7.03 M 9.86 M 26.35 M 37.22 M 58.71 M
Current Assets 8.13 M 11.58 M 29.09 M 40.18 M 59.32 M
Current Liabilities 2.21 M 2.43 M 3.26 M 1.22 M 1.55 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -2.3 -1.5
P/B 2.6 1.6
ROE % -135.8 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3